GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Capex-to-Operating-Income

Lombard Medical Technologies (LSE:LMT) Capex-to-Operating-Income : 0.00 (As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Lombard Medical Technologies's Capital Expenditure for the six months ended in Dec. 2012 was £-0.14 Mil. Its Operating Income for the six months ended in Dec. 2012 was £-8.24 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Lombard Medical Technologies Capex-to-Operating-Income Historical Data

The historical data trend for Lombard Medical Technologies's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Capex-to-Operating-Income Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lombard Medical Technologies's Capex-to-Operating-Income

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lombard Medical Technologies's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's Capex-to-Operating-Income falls into.



Lombard Medical Technologies Capex-to-Operating-Income Calculation

Lombard Medical Technologies's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2012 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.137) / -8.244
=N/A

Lombard Medical Technologies's Capex-to-Operating-Income for the quarter that ended in Dec. 2012 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.137) / -8.244
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lombard Medical Technologies  (LSE:LMT) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Lombard Medical Technologies Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Lombard Medical Technologies (LSE:LMT) Business Description

Traded in Other Exchanges
N/A
Address
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.